The Effects of Polychlorinated Biphenyls on Adipocyte-Macrophage Crosstalk
Project Number1F30ES035622-01A1
Former Number1F30ES035622-01
Contact PI/Project LeaderBEHAN-BUSH, RILEY
Awardee OrganizationUNIVERSITY OF IOWA
Description
Abstract Text
Project Summary/Abstract
Polychlorinated biphenyls (PCBs) are a group of environmental toxins that has been linked to an increased risk
of heart disease, stroke, and cancer, as well as the development of metabolic syndromes such as obesity,
hyperlipidemia, and type II diabetes. Metabolic diseases are characterized by both systemic and local
inflammation with adipose tissue, the primary site of PCB accumulation. Adipose tissue is comprised of many
cell types including adipocytes, adipose mesenchymal stem cells (MSCs), endothelial cells, and immune cells
such as macrophages. Adipose tissue macrophages (ATMs) play an integral role in regulating the inflammatory
state of adipose tissue and influencing adipocyte function. During the pathological expansion of adipose tissue,
adipocytes become inflamed beginning a cascade of immune cell activation starting with ATMs. The changing
adipocyte secretion profile polarizes the macrophages from an anti-inflammatory phenotype toward an
inflammatory phenotype and increases the infiltration of macrophage precursors into adipose tissue.
Furthermore, these inflammatory ATMs communicate with local adipocytes through the release of soluble factors
causing additional metabolic disruption and lipid accumulation in adipocytes. Despite the essential role of ATMs
in the regulation of adipocyte function and the known accumulation of PCBs in adipose tissue, little is known
about how PCBs affect adipose through ATMs. We have previously shown that PCB-exposed adipocytes have
decreased adiponectin and increased IL-8 secretion, two cytokines implicated in macrophage phenotype
switching. Additionally, we have shown that macrophages exposed to PCBs are polarized toward a more
inflammatory phenotype. The objective of this proposed research is to determine how PCBs alter adipocyte-
macrophage crosstalk to influence the development of endocrine and metabolic disruption. We hypothesize that
adipocyte-macrophage communication will be altered by PCB exposure resulting in functional changes for both
cell types. Our approach to testing this hypothesis is divided into two aims. In Aim 1, we will assess how PCB-
exposed adipocytes affect macrophage recruitment and polarization. In Aim 2, we will investigate how PCB-
exposed macrophages affect adipocyte phenotype and adipogenesis. Through the completion of these aims, we
will uncover the systems-level mechanisms by which PCBs contribute to adipose dysfunction and inflammation
through the disruption of adipocyte-macrophage crosstalk. More broadly, this fellowship will help me achieve my
goals of gaining experience in medicine, toxicology, bioengineering, and environmental chemistry to prepare for
a future career in treating and researching diseases impacted by endocrine-disrupting chemicals.
Public Health Relevance Statement
Project Narrative
Polychlorinated biphenyls (PCBs) persist in the built and natural environment leading to human exposure and
increased risk of metabolic diseases such as diabetes and obesity. The development of metabolic diseases
often begins in adipose tissue, the lipid-rich depot also responsible for PCB accumulation. This project will
uncover the systems-level mechanisms by which PCBs contribute to adipose dysfunction and inflammation
through the disruption of cellular crosstalk between adipocytes and macrophages.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
062761671
UEI
Z1H9VJS8NG16
Project Start Date
01-July-2024
Project End Date
30-June-2027
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$40,427
Direct Costs
$40,427
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Environmental Health Sciences
$40,427
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F30ES035622-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F30ES035622-01A1
Patents
No Patents information available for 1F30ES035622-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F30ES035622-01A1
Clinical Studies
No Clinical Studies information available for 1F30ES035622-01A1
News and More
Related News Releases
No news release information available for 1F30ES035622-01A1
History
No Historical information available for 1F30ES035622-01A1
Similar Projects
No Similar Projects information available for 1F30ES035622-01A1